ArticleCureus2025
Immature Platelet Fraction and Other Platelet Indices in Type 2 Diabetes Mellitus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating convolutional neural networks with ensemble methods for enhanced diabetes diagnosis: a multi-dataset evaluation.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus (DM) has become a significant global health concern, with its associated complications imposing a substantial burden on healthcare systems worldwide. While it is widely recognized as a complex metabolic disorder, the understanding of its pathophysiology continues to evolve, leading to the identification of various diabetes subtypes and their diverse clinical presentations. Despite extensive research, the impact of diabetes on platelet function remains a lesser explored domain.
methodsWe conducted a case-control study to investigate the variation of platelet indices in individuals with type 2 diabetes mellitus (T2DM) compared to healthy controls. Our study, conducted at a tertiary care facility in the national capital region, aimed to identify potential prognostic markers and explore the utility of platelet indices in predicting diabetic complications. A total of 230 participants, including 115 T2DM cases and 115 age and sex-matched healthy controls, were enrolled in the study. Baseline investigations, including hemogram and platelet indices, were performed and statistical analyses were conducted to compare the results between the two groups.
resultsSignificant differences were found in platelet parameters between T2DM cases and controls, with elevated levels observed in individuals with T2DM. Immature platelet fraction (IPF), mean platelet volume, plateletcrit, platelet distribution width, platelet large cell count, and platelet large cell ratio were among the parameters that were significantly elevated in individuals with T2DM. Furthermore, IPF emerged as a promising biomarker, demonstrating excellent diagnostic performance with an area under the ROC curve of 0.941. A cutoff value of IPF (%) ≥9.6 showed high sensitivity (86%) and specificity (95%) in distinguishing T2DM cases from controls.
conclusionOur study provides novel insights into the relationship between platelet indices and T2DM, highlighting the potential utility of IPF as a prognostic marker in diabetic individuals. These findings warrant further investigation in larger cohorts and prospective studies to validate the proposed cutoff values and explore their clinical and therapeutic implications in the management of T2DM and delaying its complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.